Lüneburg, Germany, 10 April 2014 – Novo Nordisk, the world market leader in diabetes care, implemented PAS-X V3.1.5 successfully at their Brazilian site in Montes Claros. With 18 production lines in five process areas, including lines for formulation, filling, inspection, assembling and packaging insulin pens, and two lines for tablet packaging, Montes Claros is one of the company’s largest sites.
By providing "PAS-X Reports & Labels" Content Packages, Werum Software & Systems now offers an even broader range of pre-configured reports and labels along with the associated comprehensive consulting services to its customers.
In order for pharma and biotech customers to implement PAS-X MES projects even faster and more easily, Werum Software & Systems expands its PAS-X Content Packages offering further: New on the market are the "PAS-X MBR Design Elements" Content Packages.
EFM Plug-In for TOP Server Updated With Generic ODBC Database Exporter; New Enhancements Released for Allen-Bradley ControlLogix Slave Ethernet, Fisher ROC Drivers and Support for Demand-Only Polling
The pharmaceutical major Dr. Reddy’s Laboratories Ltd. successfully rolled out Werum’s PAS-X Manufacturing IT Business Platform at their Indian greenfield site in Visakhapatnam. Dr. Reddy’s deployed PAS-X for the first time as full-blown MES covering all operations from material receipt to production.
The largest pharmaceutical company in Southeast Asia, PT Kalbe Farma Tbk., has successfully started up PAS-X at its headquarters in Jakarta, Indonesia. Kalbe modernized its IT and MES infrastructures and chose Werum’s PAS-X to fully integrate with the Oracle EBS system.
New Pricing Model Combines OPC Data.NET, OPC Data-COM and OPC Data-UA Products Into One Installer, With One License; Sold as Standard or Ultimate Edition
Security Policies Plug-In for TOP Server Offers Flexible User Control; New Drivers and Enhancements Released for Allen-Bradley Micro800 and Fisher ROC and DNP
The research-based international pharmaceutical company Grünenthal will deploy the PAS-X PROCESS DEVELOPMENT package. The group is leading in the field of pain therapies and invests more than a quarter of its revenues in research and development.
